Fibrolytic vaccination against ADAM12 reduces desmoplasia in preclinical pancreatic adenocarcinomas.
Chen J, Sobecki M, Krzywinska E, Thierry K, Masmoudi M, Nagarajan S, Fan Z, He J, Ferapontova I, Nelius E, Seehusen F, Gotthardt D, Takeda N, Sommer L, Sexl V, Münz C, DeNardo D, Hennino A, Stockmann C.
Chen J, et al. Among authors: fan z.
EMBO Mol Med. 2024 Oct 30. doi: 10.1038/s44321-024-00157-4. Online ahead of print.
EMBO Mol Med. 2024.
PMID: 39478152